TypeName: Business Offer
Offer Date:2018/09/29
Country: United States
Summary: BMS-911543 is an orally available small molecule targeting a subset of Janus-associated kinase (JAK) with potential antineoplastic activity. JAK2 inhibitor BMS-911543 selectively inhibits JAK2, thereby preventing the JAK/STAT (signal transducer and activator of transcription) signaling cascade, including activation of STAT3. This may lead to an induction of tumor cell apoptosis and a decrease in cellular proliferation. JAK2, often upregulated or mutated in a variety of cancer cells, mediates STAT3 activation and plays a key role in tumor cell proliferation and survival.
https://www.bocsci.com/bms-911543-cas-1271022-90-2-item-457828.html
Description: [RequestDescription]
OfferId: 2159
Name:Alex Brown
Telphone: